| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |